January 2025 Br J Cardiol 2025;32(1) doi:10.5837/bjc.2025.004 Online First
Hibba Kurdi, Henry Procter, Matthew Aldred, Katie Linden, Angela Langton, Akriti Naraen, Kathryn Abernethy, Sabrina Nordin, Ashwin Roy, Ben Leach, James Moon, Derralynn Hughes
Introduction Fabry disease is a rare X-chromosome-linked disorder that results from alpha-galactosidase A enzyme deficiency. It is broadly divided into classical (earlier onset, low enzyme activity) and non-classical (milder, later-onset and some residual activity). It is underdiagnosed despite the availability of diagnostic tests, such as blood (plasma or leucocyte alpha-galactosidase A enzyme) and genetic testing. Due to its heterogeneous nature as a multi-system disorder, Fabry disease (FD) is rarely considered. Patients often present with non-specific symptoms, such as fatigue and gastrointestinal symptoms akin to irritable bowel, taking
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits